Onco-Innovations Adjusts Pricing for Private Placement

Onco-Innovations Limited announced a revision in the pricing of its non-brokered private placement. The company plans to issue up to 3,076,923 units at $0.65 each, aiming to raise a total of $2,000,000. Each unit comprises one common share and one purchase warrant, exercisable at $0.75 within three years.

An administrative fee will be paid with shares equal to 1.0% of the total issued. Finders' fees might also be paid in cash or warrants. The completion is subject to regulatory approvals, and securities will hold a period of four months and one day.

The funds are intended for corporate, operational, and research purposes. The securities are not registered under U.S. law, and this announcement is not a sales offer in jurisdictions where it is unlawful.